The study of Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1, Cha et al
Published: 12 July 2018| Version 1 | DOI: 10.17632/g66zzcbvfx.1
Contributor:
Jong-ho chaDescription
This data is raw data of The study of Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1, Cha et al published on Molecular Cell.
Files
Institutions
University of Texas MD Anderson Cancer Center
Categories
Cancer Immunotherapy